CXCL12 Protein
Quick Overview for CXCL12 Protein (ABIN2018349)
Target
See all CXCL12 ProteinsProtein Type
Biological Activity
Origin
Source
Purity
- 
    - 
                                            Sequence
- KPVSLSYRCP CRFFESHIAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNK
- 
                                            Characteristics
- Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human peripheral blood monocytes is in a concentration range of 50-100 ng/mL.
- 
                                            Sterility
- 0.2 μm filtered
- 
                                            Endotoxin Level
- < 1 EU/μg of rMuSDF-1μ/CXCL12μ as determined by LAL method.
 
- 
                                            
- 
    Want other Options for this Protein ?!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions 
- 
    
- 
    - 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Reconstitution
- We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
- 
                                            Buffer
- Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
- 
                                            Handling Advice
- Avoid repeated freeze/thaw cycles.
- 
                                            Storage
- 4 °C/-20 °C
- 
                                            Storage Comment
- This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C.
 
- 
                                            
- 
    - CXCL12 (Chemokine (C-X-C Motif) Ligand 12 (CXCL12))
- 
                                            Alternative Name
- SDF-1 alpha/cxcl12
- 
                                            Background
- 
                        Stromal-Cell Derived Factor-1 alpha/ CXCL12 (SDF-1a) and SDF-1b, members of the chemokine alpha subfamily that lack the ELR domain, were initially identified using the signal sequence trap cloning strategy from a mouse bone-marrow stromal cell line. These proteins were subsequently also cloned from a human stromal cell line as cytokines that supported the proliferation of a stromal cell-dependent pre-B-cell line. SDF-1a and SDF-1b cDNAs encode precursor proteins of 89 and 93 amino acid residues, respectively. Both SDF-1a and SDF-1b are encoded by a single gene and arise by alternative splicing. The two proteins are identical except for the four amino acid residues that are present in the carboxy-terminus of SDF-1b and absent from SDF-1a. SDF-1/PBSF is highly conserved between species, with only one amino acid substitution between the mature human and mouse proteins. SDF-1/PBSF acts via the chemokine receptor CXCR4 and has been shown to be a chemoattractant for T-lymphocytes, monocytes, pro- and pre- B cells, but not neutrophils. Mice lacking SDF-1 or CXCR4 have been found to have impaired B-lymphopoiesis, myelopoiesis, vascular development, cardiogenesis and abnormal neuronal cell migration and patterning in the central nervous system.
 Synonyms: Murine Stromal-Cell Derived Factor-1 alpha
- 
                                            Molecular Weight
- 8.0 kDa, a single non-glycosylated polypeptide chain containing 68 amino acids.
- 
                                            Pathways
- Regulation of Cell Size, CXCR4-mediated Signaling Events, Negative Regulation of intrinsic apoptotic Signaling
 Target
- 
                    
 
                                     
                                     
                                    